These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28592100)

  • 21. Aflatoxin B
    Chu YJ; Yang HI; Wu HC; Liu J; Wang LY; Lu SN; Lee MH; Jen CL; You SL; Santella RM; Chen CJ
    Int J Cancer; 2017 Aug; 141(4):711-720. PubMed ID: 28509392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relation of polymorphisms of the XPD and GSTM1 genes with susceptibility to hepatocellular carcinoma in Qinghai Tibetans].
    Zhao JH; Li H; Di J
    Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):831-6. PubMed ID: 25531380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa.
    Groopman JD; Hall AJ; Whittle H; Hudson GJ; Wogan GN; Montesano R; Wild CP
    Cancer Epidemiol Biomarkers Prev; 1992; 1(3):221-7. PubMed ID: 1339082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma.
    Long XD; Zhao D; Wang C; Huang XY; Yao JG; Ma Y; Wei ZH; Liu M; Zeng LX; Mo XQ; Zhang JJ; Xue F; Zhai B; Xia Q
    Epidemiology; 2013 Sep; 24(5):671-81. PubMed ID: 23788213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aflatoxins as a risk factor for hepatocellular carcinoma in Egypt, Mansoura Gastroenterology Center study.
    Abdel-Wahab M; Mostafa M; Sabry M; el-Farrash M; Yousef T
    Hepatogastroenterology; 2008; 55(86-87):1754-9. PubMed ID: 19102385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma.
    Chen CJ; Yu MW; Liaw YF; Wang LW; Chiamprasert S; Matin F; Hirvonen A; Bell DA; Santella RM
    Am J Hum Genet; 1996 Jul; 59(1):128-34. PubMed ID: 8659516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aflatoxin and PAH exposure biomarkers in a U.S. population with a high incidence of hepatocellular carcinoma.
    Johnson NM; Qian G; Xu L; Tietze D; Marroquin-Cardona A; Robinson A; Rodriguez M; Kaufman L; Cunningham K; Wittmer J; Guerra F; Donnelly KC; Williams JH; Wang JS; Phillips TD
    Sci Total Environ; 2010 Nov; 408(23):6027-31. PubMed ID: 20870273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary 15-F2t-isoprostane, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan.
    Wu HC; Wang Q; Yang HI; Ahsan H; Tsai WY; Wang LY; Chen SY; Chen CJ; Santella RM
    Carcinogenesis; 2008 May; 29(5):971-6. PubMed ID: 18310087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary modulation of the biotransformation and genotoxicity of aflatoxin B(1).
    Gross-Steinmeyer K; Eaton DL
    Toxicology; 2012 Sep; 299(2-3):69-79. PubMed ID: 22640941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of aflatoxin M1-N7-guanine in liver and urine of tree shrews and rats following administration of aflatoxin B1.
    Egner PA; Yu X; Johnson JK; Nathasingh CK; Groopman JD; Kensler TW; Roebuck BD
    Chem Res Toxicol; 2003 Sep; 16(9):1174-80. PubMed ID: 12971806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecal and urinary excretion of aflatoxin B1 metabolites (AFQ1, AFM1 and AFB-N7-guanine) in young Chinese males.
    Mykkänen H; Zhu H; Salminen E; Juvonen RO; Ling W; Ma J; Polychronaki N; Kemiläinen H; Mykkänen O; Salminen S; El-Nezami H
    Int J Cancer; 2005 Jul; 115(6):879-84. PubMed ID: 15723309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans.
    McGlynn KA; Hunter K; LeVoyer T; Roush J; Wise P; Michielli RA; Shen FM; Evans AA; London WT; Buetow KH
    Cancer Res; 2003 Aug; 63(15):4594-601. PubMed ID: 12907637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative comparison of aflatoxin B1 serum albumin adducts in humans by isotope dilution mass spectrometry and ELISA.
    Scholl PF; Turner PC; Sutcliffe AE; Sylla A; Diallo MS; Friesen MD; Groopman JD; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):823-6. PubMed ID: 16614131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification and validation of enzyme immunoassay for urinary aflatoxin B1-N7-guanine adduct for biological monitoring of aflatoxins.
    Nayak S; Sashidhar RB; Bhat RV
    Analyst; 2001 Feb; 126(2):179-83. PubMed ID: 11235100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do aflatoxin-DNA adduct measurements in humans provide accurate data for cancer risk assessment?
    Groopman JD
    IARC Sci Publ; 1988; (89):55-62. PubMed ID: 3143672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aflatoxin exposure in Singapore: blood aflatoxin levels in normal subjects, hepatitis B virus carriers and primary hepatocellular carcinoma patients.
    Chao TC; Lo DS; Bloodworth BC; Gunasegaram R; Koh TH; Ng HS
    Med Sci Law; 1994 Oct; 34(4):289-98. PubMed ID: 7830511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associated factors in modulating aflatoxin B1-albumin adduct level in three Chinese populations.
    Tao P; Zhi-Ming L; Tang-Wei L; Le-Qun L; Min-Hao P; Xue Q; Lu-Nam Y; Ren-Xiang L; Zong-Liang W; Lian-Wen W; Qiao W; Han-Ming S; Choon-Nam O; Santella RM
    Dig Dis Sci; 2005 Mar; 50(3):525-32. PubMed ID: 15810636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma.
    Ross RK; Yuan JM; Yu MC; Wogan GN; Qian GS; Tu JT; Groopman JD; Gao YT; Henderson BE
    Lancet; 1992 Apr; 339(8799):943-6. PubMed ID: 1348796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between exposure to aflatoxin, mutation in TP53, infection with hepatitis B virus, and occurrence of liver disease in a selected population in Hyderabad, India.
    Anitha S; Raghunadharao D; Waliyar F; Sudini H; Parveen M; Rao R; Kumar PL
    Mutat Res Genet Toxicol Environ Mutagen; 2014 May; 766():23-8. PubMed ID: 24657665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aflatoxin-albumin adduct formation after single and multiple doses of aflatoxin B(1) in rats treated with Thai medicinal plants.
    Vinitketkumnuen U; Chewonarin T; Dhumtanom P; Lertprasertsuk N; Wild CP
    Mutat Res; 1999 Jul; 428(1-2):345-51. PubMed ID: 10518006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.